Cardiovascular Risk A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure

@inproceedings{Savarese2012CardiovascularRA,
  title={Cardiovascular Risk A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure},
  author={Gianluigi Savarese and Pierluigi Costanzo and John George Franklin Cleland and Enrico Vassallo and Donatella Ruggiero and Giuseppe M.C. Rosano and Pasquale Perrone-Filardi},
  year={2012}
}
Results ACE-Is significantly reduced the risk of the composite outcome (odds ratio [OR]: 0.830 [95% confidence interval (CI): 0.744 to 0.927]; p 0.001), MI (OR: 0.811 [95% CI: 0.748 to 0.879]; p 0.001), stroke (OR: 0.796 [95% CI: 0.682 to 0.928]; p 0.004), all-cause death (OR: 0.908 [95% CI: 0.845 to 0.975]; p 0.008), new-onset HF (OR: 0.789 [95% CI: 0.686 to 0.908]; p 0.001), and new-onset DM (OR: 0.851 [95% CI: 0.749 to 0.965]; p 0.012). ARBs significantly reduced the risk of the composite… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 16 times over the past 90 days. VIEW TWEETS